Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents

Table 1

Baseline demographic and ocular data.

	Group 1	Group 2	value
Patients ()	107	27	—
Mean age, years	64.6	66.1	0.24
Male : female	106 : 1	27 : 0	0.99
White	59 (55.1%)	16 (59.2%)	0.33
African American	32 (29.9%)	6 (22.2%)
Hispanic	6 (5.6%)	4 (14.8%)
Other	10 (9.34%)	1 (3.70%)
HbA1c	8.42%	8.17%	0.43
Mean follow-up	19.7 months	17 months	0.29
Eyes ()	150	42	—
Phakic	126 (84%)	33 (79%)	0.46
Mean initial BCVA, logMAR	0.47 (20/59)	0.55 (20/70)	0.096
Mean initial CSMT	424 μm	429 μm	0.43
Mean initial IOP	14.2 mmHg	14.1 mmHg	0.91